CoChat

Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up

Open access
Eilat-Tsanani, Sophia, Margalit, Avital, Golan, Liran Nevet · 2021 · Scientific Reports

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

The burden of type 2 diabetes is growing, not only through increased incidence, but also through its comorbidities. Concordant comorbidities for type 2 diabetes, such as cardiovascular diseases, are considered expected outcomes of the disease or disease complications, while discordant comorbidities are not considered to be directly related to type 2 diabetes and are less extensively addressed under diabetes management. Here we show that the combination of concordant and discordant comorbidities appears frequently in persons with diabetes (75%). Persons with combined comorbidities visited family physicians more than persons with discordant, concordant or no comorbidity (17.3 ± 10.2, 11.6 ± 6.5, 8.7 ± 6.8, 6.3 ± 6.6 visits/person/year respectively, p < 0.0001). The risk of death during the study period was highest in persons with combined comorbidities and discordant only comorbidities (HR = 33.4; 95% CI 12.5–89.2 and HR = 33.5; 95% CI 11.7–95.8), emphasizing the contribution of discordant comorbidities to the outcome. Our study is unique as a long-term follow-up of an 11-year cohort of 9725 persons with new-onset type 2 diabetes. The findings highlight the contribution of discordant comorbidity to the burden of the disease. The high prevalence of the combination of both concordant and discordant comorbidities, and their appearance before the onset of type 2 diabetes, indicates a continuum of morbidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-90379-0

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of the study sample.
Figure 1 Flow chart of the study sample.CC BY · PubMed Central
Figure 2 Distribution of number of diseases in persons from various groups of comorbidity. In persons with concordant or discordant comorbidities only, diseases were distributed across a smaller range compared to persons with combined comorbidities.
Figure 2 Distribution of number of diseases in persons from various groups of comorbidity. In persons with concordant or discordant comorbidities only, diseases were distributed across a smaller range compared to persons with combined comorbidities.CC BY · PubMed Central
Figure 3 Annual health care services use visits to physicians in the community (mean visits/person/year or mean hospitalizations/person/year) and comorbidity during the study period. (A) Visits to family physicians; (B) visits to consultants; (C) hospitalizations (hospitalization/person/year).
Figure 3 Annual health care services use visits to physicians in the community (mean visits/person/year or mean hospitalizations/person/year) and comorbidity during the study period. (A) Visits to family physicians; (B) visits to consultants; (C) hospitalizations (hospitalization/person/year).CC BY · PubMed Central
Figure 4 Kaplan–Meier plot of survival probabilities by comorbidity group: the comparison between comorbidities groups regarding time to death was significant using a Log-Rank test (p value < 0.0001).
Figure 4 Kaplan–Meier plot of survival probabilities by comorbidity group: the comparison between comorbidities groups regarding time to death was significant using a Log-Rank test (p value < 0.0001).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. Cohen, R. & Rabin, G. National Insurance Institute R and PA. Membership in sick funds 2016 [Hebrew]. Period Surv. 289, 4 (2017).

Cited by

See all 28

Metadata

Authors
Eilat-Tsanani, S., Margalit, A., & Golan, L. N.
Affiliations
Bar-Ilan University (IL)
Venue
Scientific Reports
Published
2021-05-26
Volume
11
Issue
1
Pages
11071-11071
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3165029143
Cited by
28
References
33
Citations by year
2026: 6 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 1
FWCI
2.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Clalit Health Services
Topics
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, comorbidities, cardiovascular disease, mortality risk, family physician visits, newly diagnosed diabetes, long-term follow-up, disease burden
MeSH terms
Adult, Aged, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Comorbidity, Incidence, Prevalence, Age of Onset, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up. https://app.cochat.ai/papers/10.1038/s41598-021-90379-0
The paper
Eilat-Tsanani, S., Margalit, A., & Golan, L. N. (2021). Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up. Scientific Reports. https://doi.org/10.1038/s41598-021-90379-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.